Top Abstract Purchase Related
Home
>
Node
>
Subnode

Managing HIV. Part 4: Primary therapy. 4.1 Antiretroviral therapies for HIV

Crowe, S.; Cooper, D.A.; Chambers, D.E.

Medical Journal of Australia 164(5): 290-295

1996

ISSN/ISBN: 0025-729X
PMID: 8628165
Document Number: 465409
Zidovudine (AZT) is not the only drug with some effect on HIV. New agents and better-directed use of established agents can delay progression of the disease and prevent the onset of symptoms for some time.

Document emailed within 1 workday
Secure & encrypted payments

Lesho, E.P.; Gey, D.C. 2003: Managing issues related to antiretroviral therapy American Family Physician 68(4): 675-686
Rawlings, M.K.; Smith, K.Y. 2004: Recognizing and managing common toxicities in patients receiving antiretroviral therapy Aids Reader 14(10 Suppl): S12-S15
Harries, A.D.; Zachariah, R.; Jahn, A.; Schouten, E.J.; Kamoto, K. 2009: Scaling up antiretroviral therapy in Malawi-implications for managing other chronic diseases in resource-limited countries Journal of Acquired Immune Deficiency Syndromes 52(Suppl 1): S14-S16
Carl, W. 1988: Managing the oral manifestations of cancer therapy, Part II: Chemotherapy Compendium 9(5): 376; 378 380 Passim
Stewart, G.J.; Irvine, S.S.; Scott, M.; Kelleher, A.D.; Marriott, D.J.; McKnight, I.; Pethebridge, A.M.; Wodak, A.; Ziegler, J. 1996: Managing HIV. Part 1: Principles. 1.2 Strategies of care in managing HIV Medical Journal of Australia 164(2): 99-104
Stephens, J.R.; Rathbun, R.C.; Lockhart, S.M.; Bronze, M.S.; Greenfield, R.A. 2007: Part XV. Antiretroviral therapy for human immunodeficiency virus infection Journal of the Oklahoma State Medical Association 100(11): 417-424
Pujol, L.A.Menefee.; Monti, D.A. 2007: Managing cancer pain with nonpharmacologic and complementary therapies Journal of the American Osteopathic Association 107(12 Suppl. 7): Es15-Es21
Claveau, J.; Ho, V.; Petrella, T. 2014: Metastatic melanoma: optimizing outcomes by managing dermatologic toxicities associated with novel therapies Skin Therapy Letter 19(2): 1-4
Grothey, A. 2006: Recognizing and managing toxicities of molecular targeted therapies for colorectal cancer Oncology 20(14 Suppl 10: 21-28
Meintjes, G.; Black, J.; Conradie, F.; Dlamini, S.; Maartens, G.; Manzini, T.C.; Mathe, M.; Moorhouse, M.; Moosa, Y.; Nash, J.; Orrell, C.; Venter, F.; Wilson, D. 2015: Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy Southern African journal of HIV medicine 16(1): 428
Alvi, Y.; Khalique, N.; Ahmad, A.; Khan, H.S.; Faizi, N. 2019: World Health Organization Dimensions of Adherence to Antiretroviral Therapy: a Study at Antiretroviral Therapy Centre, Aligarh Indian Journal of Community Medicine: Official Publication of Indian Association of Preventive and Social Medicine 44(2): 118-124
Sharma, S.; Khadga, P.; Dhungana, G.P.; Chitrakar, U. 2013: Medication adherence to antiretroviral therapy among patients visiting antiretroviral therapy center at Tribhuvan University Teaching Hospital, Kathmandu Nepal Kathmandu University Medical Journal 11(41): 50-53
Muhamadi, L.; Nsabagasani, X.; Tumwesigye, M.Nazarius.; Wabwire-Mangen, F.; Ekström, A-Mia.; Peterson, S.; Pariyo, G. 2010: Inadequate pre-antiretroviral care, stock-out of antiretroviral drugs and stigma: policy challenges/bottlenecks to the new WHO recommendations for earlier initiation of antiretroviral therapy (CD<350 cells/microL) in eastern Uganda Health Policy 97(2-3): 187-194
Mahy, M.; Lewden, C.; Brinkhof, M.W.G.; Dabis, F.; Tassie, J.-M.; Souteyrand, Y.; Stover, J. 2010: Derivation of parameters used in Spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy Sexually Transmitted Infections 86(Suppl 2): Ii28-Ii34
Mubiana-Mbewe, M.; Bolton-Moore, C.; Banda, Y.; Chintu, N.; Nalubamba-Phiri, M.; Giganti, M.; Guffey, M.B.; Sambo, P.; Stringer, E.M.; Stringer, J.S.A.; Chi, B.H. 2009: Causes of morbidity among HIV-infected children on antiretroviral therapy in primary care facilities in Lusaka, Zambia Tropical Medicine and International Health: Tm and Ih 14(10): 1190-1198
Minsky, B.D. 1999: Carcinoma of the esophagus. Part 1: Primary therapy Oncology 13(9): 1225-1232; 1235-1236
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Mosam, A.; Shaik, F.; Uldrick, T.S.; Esterhuizen, T.; Friedland, G.H.; Scadden, D.T.; Aboobaker, J.; Coovadia, H.M. 2012: A Randomized Controlled Trial of Highly Active Antiretroviral Therapy Versus Highly Active Antiretroviral Therapy and Chemotherapy in Therapy-Naive Patients With HIV-Associated Kaposi Sarcoma in South Africa Journal of Acquired Immune Deficiency Syndromes (1999) 60(2): 150-157
Wutoh, A.K.; Brown, C.M.; Kumoji, E.K.; Daftary, M.S.; Jones, T.; Barnes, N.A.; Powell, N.J. 2001: Antiretroviral adherence and use of alternative therapies among older HIV-infected adults Journal of the National Medical Association 93(7-8): 243-250
Chotmongkol, V.; Pesee, M. 2002: AIDS-related primary central nervous system lymphoma: prolonged remission associated with highly active antiretroviral therapy Journal of the Medical Association of Thailand 85(5): 634-637